Biopsy – Global Market Outlook (2017-2023)” report has been
added to ResearchAndMarkets.com’s offering.
The Global Liquid Biopsy market is expected to grow from $310 million in
2016 to reach $1,201.52 million by 2023 with a CAGR of 21.3%.
Increasing research & developments and clinical trials for diagnostics,
and technological developments are some of the factors driving the
market growth. Moreover, growing prevalence of cancer, increasing
awareness about liquid biopsy are the factors fostering the market
growth. On the other hand, higher costs and complex regulations are
restraining the market growth.
The circulating tumor cells leads the market globally with the largest
market share and is expected to grow with a highest CAGR during the
forecast period. By cancer type, lung cancer segment is expected to
witness high growth rate during the forecast period.
North America emerged as the major revenue generating region in the
global market due to innovative technological developments, and
increasing incidence of cancer rates in the Canada and U.S.
What the report offers:
Key Topics Covered
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Liquid Biopsy Market, By Clinical Application
6 Global Liquid Biopsy Market, By Product and Service
7 Global Liquid Biopsy Market, By Cancer Type
8 Global Liquid Biopsy Market, By Circulating Biomarker
9 Global Liquid Biopsy Market, By Sample Type
10 Global Liquid Biopsy Market, By End-User
11 Global Smart Lock Market, By Geography
12 Key Developments
13 Company Profiling
For more information about this report visit https://www.researchandmarkets.com/research/vcwg28/global_liquid?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180615005774/en/